Mesothelioma, Malignant Pleural
2 clinical trials · Condition
◉ Watch Mesothelioma, Malignant Pleural
| Record | Firm | Date |
|---|---|---|
| First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma (NCT05188859) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-09-01 |
| Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS (NCT06886672) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2023-06-15 |
Track Mesothelioma, Malignant Pleural automatically
Every clearance here is in the API, with alerts when new ones post.